Cell therapy manufacturing is uniquely vulnerable to contamination, variability, and operational burden because the product - ...
The mass production of pharmaceuticals has significantly evolved since the industrial fabrication of synthetic drugs towards the end of the 19 th century 1 with efficient developments in process ...
As demands for aseptic manufacturing increase, partnerships with solutions providers will be key to ensuring safe, versatile and optimized drug containment.
Bio: Don Singer is a Fellow in the American Society for Quality and formerly a GSK Senior Fellow. Don has been Chair of the USP General Chapters - Microbiology Committee of Experts and a member since ...
In the pharmaceutical industry, cleanrooms are categorized based on the level of airborne particle concentration necessary to meet the cleanliness standards required for the specific manufacturing ...
As Advanced Therapeutic Medicinal Products (ATMPs) surge in popularity and the market sees an increase in therapy development and available products, contemporary manufacturing processes must align ...
(MENAFN- Market Press Release) December 6, 2025 6:40 am - Pharmig India 2025 concludes with strong industry participation, reinforcing sterility, contamination control, and GMP excellence in pharma ...
Understanding the dynamics of air patterns is crucial for environmental management and compliance with regulations. In the realm of pharmaceuticals, adhering to Good Manufacturing Practices (GMP) ...
The IsoAir ® Pro-E Remote Particle Counter from Particle Measuring Systems (PMS) is part of a facility monitoring solution. It is an efficient piece of a contamination control strategy with the help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results